Tuesday, November 5, 2024
HomeTagsBRCA-Mutated

BRCA-Mutated

LYNPARZA Approved in the US As Adjuvant Treatment for Patients With Germline

AstraZeneca and Merck & Co., Inc., known as MSD outside the US and Canada, announced LYNPARZA® (olaparib) has been approved in the US for...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics